Insights

Polycystic thyroid disease (PCTD) is a rare condition. This report details the first pediatric case of PCTD with hyperthyroidism, highlighting its occurrence in children.

Area of Science:

  • Endocrinology
  • Pediatric Endocrinology
  • Thyroidology

Background:

  • Polycystic thyroid disease (PCTD) is a rare endocrine disorder typically observed in adults with hypothyroidism.
  • This study presents the first documented case of diffuse macrocystic degeneration of the thyroid in a pediatric patient.

Observation:

  • A 6-year-old presented with a 16-month history of an enlarging polycystic thyroid and hyperthyroidism.
  • Autoimmune thyroid disease markers were negative, and there was no family history of thyroid or cystic disease.
  • The patient underwent total thyroidectomy and is now euthyroid with hormone replacement therapy.

Findings:

  • This case represents the first reported instance of PCTD in a pediatric patient associated with hyperthyroidism.
  • The hyperthyroidism was not linked to autoimmune thyroid disease, suggesting alternative underlying mechanisms.
  • The patient's condition resolved post-thyroidectomy, with ongoing management for euthyroidism.

Implications:

  • Polycystic thyroid degeneration can manifest in children, potentially leading to hyperthyroidism.
  • Further research is needed to explore the potential role of somatic activating thyrotropin-receptor gene mutations in pediatric PCTD.
  • This case expands the known clinical spectrum of PCTD and its presentation in pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
384
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
423
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
58